Duncan Walker
12Patents
4h-index
15Co-inventors
57Inventor score
Filing activity: Mar 4, 1999 → Mar 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6369086B1 | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors | Chemistry; Metallurgy | 89 | Expired |
| US7105529B2 | Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects | Chemistry; Metallurgy | 43 | Expired |
| US6387919B1 | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors | Chemistry; Metallurgy | 13 | Expired |
| US6541503B2 | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US11497743B2 | Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation | Chemistry; Metallurgy | 3 | Active |
| US11576906B2 | Inhibiting mutant IDH-1 | Human Necessities | 1 | Active |
| US11311527B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 1 | Active |
| US11013734B2 | Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation | Chemistry; Metallurgy | 0 | Active |
| US11738018B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 0 | Active |
| US11376246B2 | Inhibiting mutant IDH-1 | Human Necessities | 0 | Active |
| US11013733B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) | Human Necessities | 0 | Active |
| US11963956B2 | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.